ICU Medical

ICU Medical to Present at the KeyBanc Life Sciences & MedTech Investor Forum

Retrieved on: 
Wednesday, March 13, 2024
Webcast, SAN, ICUI, ICU Medical, ICU, Sale, Medtech

SAN CLEMENTE, Calif., March 13, 2024 (GLOBE NEWSWIRE) -- ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the KeyBanc Life Sciences & MedTech Investor Forum being held virtually March 19-20, 2024.

Key Points: 
  • SAN CLEMENTE, Calif., March 13, 2024 (GLOBE NEWSWIRE) -- ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the KeyBanc Life Sciences & MedTech Investor Forum being held virtually March 19-20, 2024.
  • ICU Medical’s presentation will be on Wednesday, March 20, 2024 at 11:15 a.m. PT (2:15 p.m.
  • Company management will also be participating in one-on-one meetings on Wednesday, March 20, 2024.
  • The presentation will be webcast live and can be accessed by going to the Company’s website at http://www.icumed.com , clicking on the Investors tab and clicking on the Event Calendar tab.

ICU Medical to Present at the Raymond James 45ᵗʰ Annual Institutional Investors Conference

Retrieved on: 
Friday, March 1, 2024
SAN, ICU, ICU Medical, Sale, Conference, ICUI, Webcast

SAN CLEMENTE, Calif., March 01, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the Raymond James 45th Annual Institutional Investors Conference being held in Orlando, Florida, March 3-6, 2024.

Key Points: 
  • SAN CLEMENTE, Calif., March 01, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the Raymond James 45th Annual Institutional Investors Conference being held in Orlando, Florida, March 3-6, 2024.
  • ICU Medical’s presentation will be on Monday, March 4, 2024 at 4:30 a.m. PT (7:30 a.m.
  • Company management will also be participating in one-on-one meetings on Monday, March 4, 2024.
  • The presentation will be webcast live and can be accessed by going to the Company’s website at http://www.icumed.com , clicking on the Investors tab and clicking on the Event Calendar tab.

ICU Medical Announces Fourth Quarter 2023 Results and Provides Fiscal Year 2024 Guidance

Retrieved on: 
Tuesday, February 27, 2024
ICU Medical, SAN, ICUI, Use, GAAP, Sale, ICU, Bank statement

Fourth quarter 2023 revenue was $587.9 million, compared to $578.0 million in the same period in the prior year.

Key Points: 
  • Fourth quarter 2023 revenue was $587.9 million, compared to $578.0 million in the same period in the prior year.
  • GAAP gross profit for the fourth quarter of 2023 was $171.6 million, as compared to $174.9 million in the same period in the prior year.
  • Adjusted diluted earnings per share for the fourth quarter of 2023 was $1.57 as compared to $1.60 for the fourth quarter of 2022.
  • Also, adjusted EBITDA was $86.3 million for the fourth quarter of 2023 as compared to $96.4 million for the fourth quarter of 2022.

Global IV Catheters Market Insights Report 2023-2029: Peripheral Inserted Central Catheters (PICCs) Leading the Charge - ResearchAndMarkets.com

Retrieved on: 
Friday, February 23, 2024
Medical Devices, Health, Diabetes, Incidence, Alzheimer's disease, Infection, ICU, USD, European, Ageing, Growth, Cancer, Conditional sentence, Stroke, Hospital, Government, Short, ICU Medical, Prevalence, Safety, Malaria, Nutrient, PICC, Life expectancy, Injury, Patient, Dementia, Tuberculosis, CVC, Developed country, COPD, Medical device

The global IV catheters market was valued at USD 4.93 billion in 2023 and is expected to reach a value of $6.64 billion by 2029, growing at a CAGR of 5.04%

Key Points: 
  • The global IV catheters market was valued at USD 4.93 billion in 2023 and is expected to reach a value of $6.64 billion by 2029, growing at a CAGR of 5.04%
    The global IV catheters market report contains exclusive data on 33 vendors.
  • BD, B Braun, Terumo, Teleflex, ICU Medical, and Nipro Medical are some leading players currently dominating the global IV catheters market.
  • The continuous growth in individuals with chronic conditions and the rapidly expanding elderly population are the primary factors fueling the global demand for peripheral IV catheters.
  • The peripheral inserted central catheters (PICCs) product segment accounted for the highest market share of over 45% of the global CIVCs market.

ICU Medical Announces Time of Fourth Quarter 2023 Earnings Conference Call

Retrieved on: 
Tuesday, February 13, 2024
ICU Medical, SAN, ICUI, Sale

SAN CLEMENTE, Calif., Feb. 13, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its fourth quarter 2023 earnings release and conference call.

Key Points: 
  • SAN CLEMENTE, Calif., Feb. 13, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its fourth quarter 2023 earnings release and conference call.
  • The Company will release its fourth quarter 2023 results on Tuesday, February 27th, 2024 at approximately 4:00 p.m.
  • ET (1:00 p.m. PT) and will be conducting a conference call concerning those results at 4:30 p.m.
  • The call can be accessed at (833) 816-1376, conference ID 10186026.

United States Syringes & Needles Market Insights Report 2023: A $10.87 Billion Market by 2028 with BD, ICU Medical, Nipro Medical, Terumo, and Cardinal Health Emerging as Prominent Players - ResearchAndMarkets.com

Retrieved on: 
Monday, December 11, 2023
Medical Supplies, Health, Nipro, Sale, Syringe, Fungal infection, Conditional sentence, Incidence, ICU Medical, Cardinal Health, Hospital, Needle, Vaccination, Vaccine, Immunization, Cardinal, Diabetes, Anthrax Vaccine Immunization Program

This report offers market size & forecast data for the US syringes & needles market.

Key Points: 
  • This report offers market size & forecast data for the US syringes & needles market.
  • This report provides a comprehensive and current market scenario of the US syringes & needles market, including the US syringes & needles market size, anticipated market forecast, relevant market segmentations, and industry trends.
  • The study considers a detailed scenario of the present US syringes & needles market and its market dynamics for 2023?2028.
  • BD, ICU Medical, Nipro Corporation, Terumo, and Cardinal Health are the key players in the US syringes and needles market.

Corsair Gaming Reports Third Quarter 2023 Financial Results; 16.5% Revenue Growth Over Prior Year; Updates Full Year Financial Outlook

Retrieved on: 
Tuesday, November 7, 2023
Technology, Mobile, Wireless, Electronic Games, Audio, Video, Entertainment, Online, Blogging, Apps, Applications, Podcast, Other Technology, Communications, Internet, Hardware, Consumer Electronics, Elgato, Virtuoso, Ecosystem, International, EBITDA, GAAP, Acquisition, FPS, Mouse, Risk, Prompter, ICU Medical, CPU, GPU, K70, LINK, Traction, CRSR, Marketplace, DIY, Corsair Gaming, Bluetooth, Video game, Reinsurance, Corsair, Q3

Net revenue was $363.2 million compared to $311.8 million in the third quarter of 2022, an increase of 16.5%.

Key Points: 
  • Net revenue was $363.2 million compared to $311.8 million in the third quarter of 2022, an increase of 16.5%.
  • Net revenue was $1,042.6 million compared to $976.4 million in the first nine months of 2022, an increase of 6.8%.
  • The robust and successful release of a steady stream of popular new game titles in 2023 is further spurring demand.
  • Corsair will host a conference call to discuss the third quarter 2023 financial results today at 2:00 p.m. Pacific Time.

ICU Medical Announces Third Quarter 2023 Results

Retrieved on: 
Monday, November 6, 2023
Bank statement, Use, ICU Medical, EBITDA, Sale, ICUI, GAAP, SAN, ICU

SAN CLEMENTE, Calif., Nov. 06, 2023 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarter ended September 30, 2023.

Key Points: 
  • SAN CLEMENTE, Calif., Nov. 06, 2023 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarter ended September 30, 2023.
  • Third quarter 2023 revenue was $553.3 million, compared to $597.9 million in the same period last year.
  • Also, adjusted EBITDA was $89.8 million for the third quarter of 2023 as compared to $92.6 million for the third quarter of 2022.
  • Vivek Jain, ICU Medical’s Chief Executive Officer, said, “Third quarter results were generally in line with our previously revised expectations."

US Anesthesia Drugs and Devices Market Set to Reach $6.83 Billion in 2023, Driven by Growing Healthcare Expenditure - ResearchAndMarkets.com

Retrieved on: 
Monday, November 6, 2023
Pharmaceutical, Health, Medical Devices, Patient, Headache, Ageing, Anesthesiology, Pain, KKR, Vomiting, Abdominal ultrasonography, Somnolence, Prevalence, AstraZeneca, Conditional sentence, Lidocaine, Anesthetic, Shivering, MAC, Envision Healthcare, Nausea, 3M, Abbott Laboratories, General Electric Company, SunMed BRT station, Growth, Fungal infection, TeamHealth, COVID-19, Inhalation, Risk, AbbVie, Device, Benzocaine, Consciousness, Becton, Dickinson and Company headquarters, Blackstone, Braun, Baxter International, Ventilation, Central nervous system, ICU Medical, ICU, Pharmaceutical industry, Dentistry, Bupivacaine, Prilocaine, Anesthesia, Ropivacaine

The US anesthesia drugs and devices market is divided into two primary segments: anesthesia drugs and anesthesia devices.

Key Points: 
  • The US anesthesia drugs and devices market is divided into two primary segments: anesthesia drugs and anesthesia devices.
  • Among these segments, anesthesia drugs currently hold the majority share, while the anesthesia devices segment is expected to experience substantial growth due to increased healthcare expenditure in the region.
  • In terms of types, the US anesthesia drugs market is categorized into General, Local, and other anesthesia.
  • The development of novel anesthesia drugs through pharmaceutical R&D is expected to create growth opportunities in the "other anesthesia drugs" segment.

ICU Medical Announces Time of Third Quarter 2023 Earnings Conference Call

Retrieved on: 
Monday, October 23, 2023
ICU Medical, Sale, ICUI, SAN, Pharmaceutical industry, Communications satellite, Video game, Webcast

SAN CLEMENTE, Calif., Oct. 23, 2023 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its third quarter 2023 earnings release and conference call.

Key Points: 
  • SAN CLEMENTE, Calif., Oct. 23, 2023 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its third quarter 2023 earnings release and conference call.
  • The Company will release its third quarter 2023 results on Monday, November 6th, 2023 at approximately 4:00 p.m.
  • ET (1:00 p.m. PT) and will be conducting a conference call concerning those results at 4:30 p.m.
  • ET (1:30 p.m. PT) on Monday, November 6th, 2023.